CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 43 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 200 | -80.0% | 0.00% | – |
| Q1 2019 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -66.7% | 1,000 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2018 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | +20.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2017 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | +20.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | 0.0% | 1,000 | -60.0% | 0.00% | – |
| Q3 2016 | $5,000 | +400.0% | 2,500 | +400.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q2 2015 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
| Q1 2015 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | +100.0% | 500 | +150.0% | 0.00% | – |
| Q1 2014 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,192,080 | $9,704,000 | 4.11% |
| Ghost Tree Capital, LLC | 219,977 | $1,790,000 | 1.06% |
| JBF Capital, Inc. | 148,178 | $1,205,000 | 0.18% |
| Polar Capital LLP | 900,604 | $7,326,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 80,000 | $651,000 | 0.15% |
| HAMILTON LANE ADVISORS LLC | 33,141 | $270,000 | 0.11% |
| Jasper Ridge Partners, L.P. | 63,996 | $521,000 | 0.03% |
| Weiss Multi-Strategy Advisers LLC | 95,000 | $773,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 550,000 | $4,474,000 | 0.01% |
| AXA S.A. | 292,625 | $2,381,000 | 0.01% |